A large proportion of patients had an invasive ductal tumor (95%), pathological stage II and III (85%), tumor histological grade II and III (80%), no lymphovascular invasion (60%), positive nodes (58%), positive ER and PR status (61% and 51%) and negative HER-2 status (55%). The gene discussed is ESR1; the disease is neoplasm.